Oramed (NASDAQ: ORMP) CSO uses 435,084 shares to cover RSU tax

NodeGuardian · 2026-04-09T13:28:48+00:00

Miriam Kidron, Oramed Pharmaceuticals' Chief Scientific Officer, sold 435,084 shares at $3.31 each to cover tax obligations from Restricted Stock Units, leaving her with 1,133,138 shares.

NodeGuardian

2026-04-09 13:28:48

Abstract generation in progress

Oramed Pharmaceuticals Inc.'s Chief Scientific Officer, Miriam Kidron, reported a tax-related disposition of 435,084 common shares to cover tax withholding obligations from vested Restricted Stock Units. The shares were valued at $3.31 each. Following this transaction, Kidron directly holds 1,133,138 shares of Oramed common stock.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.